ICRM
WST icon

Insight Capital Research & Management’s West Pharmaceutical WST Stock Holding History

Insight Capital Research & Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-32,551
Closed -$2.47M – 131
2016
Q2 		$2.47M Buy
+32,551
New +$2.37M 0.86% 67

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Insight Capital Research & Management's WST Position: Q3 2016 in Review

Insight Capital Research & Management sold out of West Pharmaceutical (WST) in Q3 2016, closing a stake of 32,551 shares — an estimated $2.47M sold.

Insight Capital Research & Management first reported a position in WST in Q2 2016 and held it in 1 quarter. The position peaked at $2.47M in Q2 2016. 280 funds tracked by Wall St. Rank hold WST as of Q3 2016.

  • Insight Capital Research & Management reported no remaining West Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • Insight Capital Research & Management sold 32,551 West Pharmaceutical shares in Q3 2016, an estimated $2.47M.
  • Insight Capital Research & Management first reported a position in West Pharmaceutical in Q2 2016 and held it in 1 quarter.
  • Insight Capital Research & Management's West Pharmaceutical position peaked at $2.47M in Q2 2016.
  • 280 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2016.

Based on Insight Capital Research & Management's 13F filing for Q3 2016, filed 24 Oct 2016.